Shire plc (ADR) (NASDAQ:SHPGY)

CAPS Rating: 4 out of 5

A pharmaceutical company that focuses on meeting the needs of the specialist physician.

Recs

0
Player Avatar tenorbob2 (< 20) Submitted: 3/8/2007 9:35:13 AM : Outperform Start Price: $61.65 SHPGY Score: +43.95

Leader in the neurostimulant market. If this prodrug lives up to expectations, it will lead the market in sales.

Featured Broker Partners


Advertisement